Everett E. Vokes to Prostate-Specific Antigen
This is a "connection" page, showing publications Everett E. Vokes has written about Prostate-Specific Antigen.
Connection Strength
0.102
-
A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res. 2004 May 15; 10(10):3365-70.
Score: 0.052
-
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma. Cancer. 2004 Jan 01; 100(1):65-71.
Score: 0.050